Background: Loss of proprioceptive function occurs after anterior cruciate ligament (ACL) rupture. Clinical, motor, and proprioceptive function is known to improve after ACL reconstruction but does not return to normal. While histological studies of human ACL allografts have been unable to demonstrate mechanoreceptor reinnervation, animal data suggest that reinnervation may occur when an autograft is used.
Approximately 200,000 anterior cruciate ligament (ACL) tears occur annually in the United States, and 50% will undergo reconstructive surgery in an attempt to restore stability. 22 The functional instability that occurs after ACL rupture is due to both loss of the mechanical restraint to excessive motion and a lack of coordinated muscle activity to compensate and stabilize the knee joint. 7 This deficiency in muscular control is thought to be due to loss of proprioceptive feedback from the ACL to the neuromuscular system. 4 The human ACL contains mechanoreceptors that detect changes in tension, acceleration, direction of movement, and the position of the knee joint. 4, 16 Loss of this sensory feedback may impair neuromuscular function and contribute to functional instability after ACL injury.
ACL reconstruction (ACLR) improves clinical, motor, and proprioceptive function compared with the injured state but does not restore it to normal. 6, 8, 10, 20, 21 Despite restoration of objective measurements of knee laxity, only 45% to 64% of patients return to preinjury levels of sport after ACLR. 2, 3 Persistent functional impairment may be due to proprioceptive loss, and histological studies of allografts have been unable to demonstrate mechanoreceptor reinnervation after ACLR in humans. 13, 17 Animal studies suggest reinnervation may occur when autograft is used 9 ; however, human data are lacking. The aim of this study was to compare the presence or absence of mechanoreceptors in allograft versus autograft after ACLR in humans.
METHODS

Specimen Harvest
Eleven patients with previous ACLR undergoing either revision ACL surgery or knee arthroscopy for other reasons from September 2012 to February 2013 were enrolled in a prospective, comparative study. Among the 11 specimens, 10 showed acceptable condition and stainability and thus were included in the study. All patients had previously undergone single-bundle ACLR, with no history of any significant posterior cruciate or collateral ligament injury, associated injury/fractures in the knee, or inflammatory arthritis. There were 7 males and 3 females, and the mean age was 33 years (range, 18-45 years).
The mean duration between primary ACL and secondlook/revision surgery was 83 months (range, 6-177 months). In revision patients, the elapsed time from reinjury to surgery ranged from 4 weeks to 2 years (Table 1) . In 4 revision patients with time from reinjury to specimen harvest >8 weeks, the graft was intact but clinically lax due to fixation failure or tunnel malposition. Five patients had a previous autograft ACL and 5 patients had a previous allograft ACL. As a control, remnant ACL tissue was taken from the tibial and femoral attachment sites of a 33-yearold male 6 weeks after acute primary ACL rupture.
In 7 patients undergoing revision ACLR, all available remnant graft tissue was excised arthroscopically using graspers and a scalpel. The tibial stump was harvested in all cases. In 3 patients with previous ACLR undergoing arthroscopy for other reasons, 2-mm punch biopsies were taken from both the tibial and femoral insertions, as described by Kim et al. 17 The harvested specimens were preserved in 10% neutral-buffered formalin solution.
Immunohistochemistry staining was used to identify the presence of neurofilament protein-positive (NFPþ) neural tissue analogs in harvested ACL tissue.
ACL Sectioning
Specimens were immersed in optimal cutting temperature (OCT) compound and frozen in preparation for frozen sectioning. The frozen sections were then sequentially sliced at 6-mm thickness, and each slide was placed on a SuperFrost Plus slide (Fisher Scientific) and serially numbered. Multiple sections of each sample were obtained from each specimen ( Figure 1 ). As a single mechanoreceptor can span several 6-mm slices, the specimen was advanced approximately 60 mm between each collected section to avoid overestimating the number of mechanoreceptors. The sections were allowed to dry at room temperature overnight before being fixed in acetone to preserve their antigenicity. Three slides were made for each patient, and each slide had 3 slices that were analyzed for a total of 9 slides per patient.
Immunohistochemical Staining
Specimens were stained using hematoxylin and monoclonal antibody against NFP. Our procedure of immunohistological staining using the Envisionþ HRP System (Dako) was as follows: The primary antibody was anti-NFP-monoclonal mouse antibody (Dako), with a dilution of 1:100. The secondary antibody was peroxidase conjugate. Endogenous peroxidase activity was blocked by adding fully prepared 0.03% hydrogen peroxidase containing sodium azide for placement in a tris-buffered wash bath for 5 minutes. The optimally diluted primary antibody (NFP) was then applied to sections followed by incubation for 30 minutes in a moist chamber. Sections were rinsed gently with buffer solution and placed in a fresh buffer bath. Labeled polymer (peroxidase-labeled polymer conjugated to goat antimouse immunoglobulins) was then applied to sections followed by incubation for 30 minutes in a moist chamber. Sections were rinsed gently with buffer solution and placed in a fresh buffer bath. Substrate-chromagen (3-3 0 -diaminobenzidine chromogen in substrate buffer) was applied to specimens followed by incubation for 7 minutes in a moist chamber. Sections were rinsed gently with distilled water. Counterstaining was done with hematoxylin for 1 minute and followed by mounting with Vectamount (Vector Laboratories).
The specificity of the staining was confirmed by running appropriate control sections with and without the primary monoclonal antibody. All incubation steps were carried out at room temperature in a humidified chamber. Multiple slices from each specimen were serially reviewed.
Interpretation of Histology
All results were interpreted by a single pathologist under a light microscope. The pathologist inspected each slide in a blinded fashion and reviewed the entirety of each section first at 10Â and then at 20Â magnification for any NFPþ neural tissue. Stained specimens were examined, cells were identified, and the number and location on the slides were marked. Positive results were given to granularly stained areas with NFP ( Figure 2 ). The NFP monoclonal antibody stained axon cylinders carrying proprioceptive fibers, and hematoxylin was used as a counterstain for detailed histological evaluation. All recordings were tracked with a manual cell counter and recorded.
Statistical Analysis
Data are expressed as the mean ± SD. An unpaired t test (Prism Software; Graphpad Software Inc) was used to compare the number of NFPþ neural tissue analogs per slide between graft and control ACL tissue, with 9 slides analyzed per patient. All statistical tests were 2-tailed, and a P value (2-tailed) <.05 was assigned as significant.
RESULTS
There were NFPþ neural tissue analogs visible in the control patient's slides ( Figure 1 ) and a reduced concentration of NFPþ-stained neural tissue analogs in the graft sections (Figure 2) . None of the entire graft specimens had more than 3 NFPþ analogs, while none of the control sections had less than 3 NFPþ analogs.
The mean number of NFPþ neural tissue analogs per slide in the autograft samples was significantly decreased compared with the control samples (0.5 ± 0.78 vs 4.7 ± 0.87, respectively; P < .0001). The number of NFPþ neural tissue analogs per slide in the allograft samples was also significantly decreased compared with the control samples (0.7 ± 0.85 vs 4.7 ± 0.87, respectively; P < .0001). In contrast, there was no statistically significant difference in the number of NFPþ neural tissue analogs in the autograft compared with allograft samples (Figure 3) .
DISCUSSION
This study found markedly reduced concentrations of NFPþ neural tissue in ACL grafts compared with native ACL tissue. This deficit persisted irrespective of graft choice and time since surgery, suggesting minimal reinnervation of ACL grafts occurs in humans. These findings may explain the continued proprioceptive deficit noted clinically after ACL reconstruction. 10 Traditionally, mechanoreceptors have been identified using histological stains such as gold chloride, 17 then classified using morphological criteria by Freeman and Wyke. 12 However, recent studies have demonstrated that immunohistochemical methods are a more reliable method of identifying mechanoreceptor tissue. 4 ,11 Fromm and Kummer 13 reported immunofluorescent stains could be used to group neurons in ACLs into 3 types, each of which can be stained with an antibody. Fast-conducting mechanoreceptive sensory afferent nerve fibers were characterized by the presence of NFP, slow-conducting nociceptive sensory efferent fibers by substance P, and sympathetic postganglionic neurons utilizing noradrenaline as transmitted were identified with antisera directed against the rate-limiting enzyme of noradrenaline synthesis, tyrosine hydroxylase. We chose to use immunohistochemical staining for NFP as our specific interest was mechanoreceptor fibers contributing to proprioception function. Two previous studies have attempted to identify mechanoreceptor reinnervation of ACL grafts in humans, with conflicting findings. Kim et al 17 analyzed tissue biopsies in 11 patients who had undergone allograft ACLR 12 to 120 months previously. They found no histological evidence of mechanoreceptor ingrowth in any biopsies. Denti et al 9 analyzed samples from 2 patients with failed ACL hamstring autografts 9 and 10 years postsurgery using gold chloride staining. They reported ''a significant number'' of Ruffini and Pacini corpuscles, particularly near the tibial insertion. Using modern immunohistochemical techniques, we were able to find evidence suggesting mechanoreceptor reinnervation in both autograft and allograft tissue, although in markedly reduced numbers, compared with our control specimen.
Data from animal studies is similarly mixed. In a rabbit model, Fromm and Kummer 13 demonstrated that no mechanoreceptors had reinnervated an ACL allograft by 52 weeks postoperatively using immunofluorescent stains for NFP. In contrast, Denti et al 9 reported histological evidence of mechanoreceptors using gold chloride stains in sheep ACL autografts. Barrack et al 5 measured somatosensory-evoked potentials (SEPs) in a canine model of ACL autografts and found that only 2 of 6 dogs showed evidence of reinnervation 6 months after ACLR.
SEPs after ACL stimulation have also been reported in humans. Ochi et al 20 compared SEPs with intraoperative stimulation between 14 patients with normal ACLs and 22 patients 18 months post-hamstring autograft ACLR. While SEPs were found in all reconstructed patients, voltages were lower than in patients with a native ACL. It should be noted that SEPs do not specifically detect mechanoreceptor function, and this finding together with data from our and other histological studies suggest any reinnervation that occurs after ACLR is incomplete.
A number of studies have analyzed the presence of mechanoreceptors in the tibial remnant after ACL rupture and prior to ACLR. In 2 studies looking at 94 ruptured ACL remnants, Bali et al 4 and Dhillon et al 11 found that mechanoreceptors were more common at insertion sites of the ACL, which was the rationale for taking biopsies at insertion sites in our study. They also found that NFPcontaining tissue was increased with shorter duration from injury, longer stumps, and stumps that showed adherence to the posterior cruciate ligament (PCL). This suggests that the number of mechanoreceptors declines after ACL rupture, and these 3 factors slow or arrest the rate of decline. Similarly, Georgoulis et al 14 analyzed 17 ACL remnants using gold chloride staining and found that mechanoreceptors were more likely to be present if the ACL remnant had healed down to the PCL. This suggests that continued stretch and stimulation may be important to the maintenance of mechanoreceptors within ACL remnants. Lee et al 18 analyzed 36 human ACL remnants using immunohistochemical staining for NFP and observed mechanoreceptors in 33% of remnants. Adachi et al 1 correlated the number of these mechanoreceptors in the tibial ACL remnant with better preoperative proprioceptive function in 29 patients. Some authors use this finding to argue for preserving the ACL tibial remnant during ACLR in an attempt to preserve proprioceptive function. 19, 22 In the future, biological techniques to promote reinnervation of grafts from stump remnants may have potential to improve proprioceptive function after ACLR.
Our findings support those of clinical studies showing neuromuscular control deficits persist many years after ACLR. Denti et al 10 used static and dynamic tests to assess motor control function in 50 patients after bone-tendonbone autograft and compared the results with 50 control subjects. They found significant motor control deficits persisted even 5 to 8 years post-ACLR. Ozenci et al 21 compared proprioceptive function in patients undergoing ACLR with allograft or autograft and found no difference between groups. Barrett 6 assessed 45 patients after ACLR and found a significant correlation between proprioceptive function and patient satisfaction, suggesting strategies to preserve such function may enhance outcome.
Limitations of this study should be noted. Consistent with previous studies, a relatively small amount of NFPþ neural tissue was detected. Sampling error may mean that mechanoreceptors were missed, particularly in patients with intact ACLs who underwent biopsy only. In an attempt to compensate for this, we harvested complete tibial stumps and took biopsy specimens at the ACL insertion, as a number of previous studies have demonstrated that ACL mechanoreceptor density is greatest at the tibial insertion. 23, 24 Second, while similar in size to a number of previous reports on this topic, 14, 15, 17, 24 the number of patients was relatively small. There was also only 1 hamstring autograft in the autograft group, and this study was not equipped to evaluate differences in types of autograft. There was also only 1 control patient; however, as expected, NFPþ tissue was clearly seen, confirming our processing technique was effective. Finally, for patients who underwent allograft ACLR, we lacked certain details of the original allograft with the potential to affect graft reinnervation, such as donor age and use of irradiation. Stimulation seems to be a requirement for maintenance of mechanoreceptors in native ACL tissue; however, we did not find evidence of mechanoreceptor reinnervation in biopsy specimens of patients with intact and wellfunctioning grafts. Lack of mechanoreceptor reinnervation in grafts is likely due to multiple factors, and may also have an effect in allograft sterilization (chemical or radiation).
CONCLUSION
We were unable to find evidence that significant mechanoreceptor reinnervation of ACL grafts occurs in humans. We also found no evidence of enhanced reinnervation when autografts were used. These data may explain the persistent proprioceptive deficit after ACLR. Further research into biological techniques to enhance reinnervation may offer a potential pathway to improve proprioceptive function after ACLR.
